抗人HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 )
-
产品编号
YR1109
-
别名
科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab
-
规格
- 1mg
- 5mg
产品介绍
| Catalog Number | YR1109 |
| Alias | 科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab |
| Size | 1mg, 5mg |
| Product Full Name | 抗人HSP91 Homolog重组抗体|科研级 Efungumab ( 依芬古单抗 ) |
| Molecular Name | Efungumab |
| CAS Number | 762260-74-2 |
| Target | HSP91 homolog[Candida albicans] |
| Antibody Isotype | scFv-heavy Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | 该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。 |
| Formulation | PBS, pH7.5 |
| Shipping Condition | 装在冰袋中运输。 |
| Background | Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues. |
| Application | FC, IP, ELISA, Neut, FuncS, IF, WB |
| Sequence | Please contact our sales representative to learn more information about this reagents. |
| Product Declaration | 仅科研使用，不得用于人体或治疗用途。 |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5栋
-
销售微信
-
官方公众号
-
400-621-6806 -
13116038708（微信同号） -
周一至周五 8:30-18:00 -
-
0
-
